
Imatinib 100 mg (Veenat) is a targeted anticancer medicine used to treat certain blood cancers, gastrointestinal stromal tumours (GIST), and selected rare disorders. It is commonly prescribed for chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It should be taken exactly as prescribed under the supervision of an oncologist.
| Generic name | Imatinib |
| Strength | 100 mg |
| Manufacturer | Natco |
| Package size | 120 Capsules |
| Used for | Blood cancers, gastrointestinal stromal tumours (GIST), and selected rare disorders |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Imatinib is a tyrosine kinase inhibitor (TKI). It blocks abnormal proteins, including BCR-ABL, KIT, and platelet-derived growth factor receptors (PDGFR), which send signals that promote cancer-cell growth and division. By inhibiting these proteins, imatinib helps slow or stop the growth of abnormal cells and control the progression of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.